Postdoctoral Fellow – EAZPOD 2024: Join EMBL-EBI’s European Bioinformatics Institute and AstraZeneca in cutting-edge computational biology projects in oncology through the EMBL-EBI–AstraZeneca Postdoctoral (EAZPOD) Programme.
| Designation | Postdoctoral Fellow – EAZPOD 2024 |
|---|---|
| Research Area | Oncology / Computational Biology |
| Location | Hinxton, near Cambridge, UK |
| Eligibility/Qualification | Applicants must hold a doctoral degree (PhD, MD, or DPhil), with less than 8 years of post-doctoral research experience, excluding absences for parental leave or health reasons. |
| Last Date for Apply | October 27, 2024 |
Job Description:
The EAZPOD Programme offers projects at the forefront of cutting-edge computational biology in oncology. The 2024 projects focus on the following areas:
- Dissecting the multicellular coordinated processes of cancer cell persistence from single-cell data.
- Partners: Julio Saez-Rodriguez and Ricardo Ramirez Flores (EMBL-EBI), Pedro Moreno and Martin Miller (AstraZeneca).
- DELPHI: Drug-Disease Interactions and Clinical Trial Applications.
- Partners: Ewan Birney and Tom Fitzgerald (EMBL-EBI), Martin Miller (AstraZeneca).
Successful candidates will have access to scientific expertise, well-equipped computational facilities, and an active seminar programme. The position is a 3-year project-based contract with a stipend of £3,307 per month after tax but excluding pension & insurances.
How to Apply:
To apply, submit a cover letter specifying the project of interest, detailing your suitability for the role and interest in the project, along with your CV and two recent letters of recommendation through the online system. For inquiries about the programme, contact via email at eazpod@ebi.ac.uk.
Last Date for Apply: October 27, 2024
